127 related articles for article (PubMed ID: 35595569)
1. KLK5 is associated with the radioresistance, aggression, and progression of cervical cancer.
Zhou S; Liu S; Tian G; Zhao L; Wang H; Li Y; Shen Y; Han L
Gynecol Oncol; 2022 Jul; 166(1):138-147. PubMed ID: 35595569
[TBL] [Abstract][Full Text] [Related]
2. Kallikrein 5 overexpression is associated with poor prognosis in uterine cervical cancer.
Chang JS; Kim N; Kim JY; Do SI; Cho Y; Kim HS; Kim YB
J Gynecol Oncol; 2020 Nov; 31(6):e78. PubMed ID: 33078588
[TBL] [Abstract][Full Text] [Related]
3.
Chuang PC; Chen PT; Wang CC; Su WH; Chen YH; Huang EY
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628336
[TBL] [Abstract][Full Text] [Related]
4. SETD3 reduces KLC4 expression to improve the sensitization of cervical cancer cell to radiotherapy.
Li Q; Zhang Y; Jiang Q
Biochem Biophys Res Commun; 2019 Aug; 516(3):619-625. PubMed ID: 31235251
[TBL] [Abstract][Full Text] [Related]
5. Targeting HMGB3/hTERT axis for radioresistance in cervical cancer.
Li Z; Zhang Y; Sui S; Hua Y; Zhao A; Tian X; Wang R; Guo W; Yu W; Zou K; Deng W; He L; Zou L
J Exp Clin Cancer Res; 2020 Nov; 39(1):243. PubMed ID: 33187536
[TBL] [Abstract][Full Text] [Related]
6. RhoC regulates radioresistance via crosstalk of ROCK2 with the DNA repair machinery in cervical cancer.
Pranatharthi A; Thomas P; Udayashankar AH; Bhavani C; Suresh SB; Krishna S; Thatte J; Srikantia N; Ross CR; Srivastava S
J Exp Clin Cancer Res; 2019 Sep; 38(1):392. PubMed ID: 31488179
[TBL] [Abstract][Full Text] [Related]
7. Aldolase A promotes cervical cancer cell radioresistance by regulating the glycolysis and DNA damage after irradiation.
Zhou J; Lei N; Qin B; Chen M; Gong S; Sun H; Qiu L; Wu F; Guo R; Ma Q; Li Y; Chang L
Cancer Biol Ther; 2023 Dec; 24(1):2287128. PubMed ID: 38010897
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-218 enhances the radiosensitivity of human cervical cancer via promoting radiation induced apoptosis.
Yuan W; Xiaoyun H; Haifeng Q; Jing L; Weixu H; Ruofan D; Jinjin Y; Zongji S
Int J Med Sci; 2014; 11(7):691-6. PubMed ID: 24843318
[TBL] [Abstract][Full Text] [Related]
9. Human kallikrein gene 5 (KLK5) expression by quantitative PCR: an independent indicator of poor prognosis in breast cancer.
Yousef GM; Scorilas A; Kyriakopoulou LG; Rendl L; Diamandis M; Ponzone R; Biglia N; Giai M; Roagna R; Sismondi P; Diamandis EP
Clin Chem; 2002 Aug; 48(8):1241-50. PubMed ID: 12142380
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of kallikrein‑related peptidase 5 is associated with the malignant behavior of colorectal cancer.
Wu Y; Chen Y; Li Q; Gong Y; Liu X; Bi L; Hu C
Mol Med Rep; 2016 Sep; 14(3):2164-70. PubMed ID: 27430713
[TBL] [Abstract][Full Text] [Related]
11. Differential splicing of KLK5 and KLK7 in epithelial ovarian cancer produces novel variants with potential as cancer biomarkers.
Dong Y; Kaushal A; Brattsand M; Nicklin J; Clements JA
Clin Cancer Res; 2003 May; 9(5):1710-20. PubMed ID: 12738725
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of HOTAIR leads to radioresistance of human cervical cancer via promoting HIF-1α expression.
Li N; Meng DD; Gao L; Xu Y; Liu PJ; Tian YW; Yi ZY; Zhang Y; Tie XJ; Xu ZQ
Radiat Oncol; 2018 Oct; 13(1):210. PubMed ID: 30355300
[TBL] [Abstract][Full Text] [Related]
13. The overexpression of PXN promotes tumor progression and leads to radioresistance in cervical cancer.
Liu Q; Wang J; Tang M; Chen L; Qi X; Li J; Yu J; Qiu H; Wang Y
Future Oncol; 2018 Feb; 14(3):241-253. PubMed ID: 29318915
[TBL] [Abstract][Full Text] [Related]
14.
Wu N; Zhang X; Zhu M; Fang C; Liu X; Wang Y; Li H; Liu S; Ting H; Qin C; Liao Q; Cai J; Wang J
Epigenetics; 2022 Dec; 17(12):1786-1799. PubMed ID: 35642528
[TBL] [Abstract][Full Text] [Related]
15. Circulating biomarker tissue kallikrein-related peptidase KLK5 impacts ovarian cancer patients' survival.
Dorn J; Magdolen V; Gkazepis A; Gerte T; Harlozinska A; Sedlaczek P; Diamandis EP; Schuster T; Harbeck N; Kiechle M; Schmitt M
Ann Oncol; 2011 Aug; 22(8):1783-90. PubMed ID: 21273346
[TBL] [Abstract][Full Text] [Related]
16. Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer.
Kim H; Scorilas A; Katsaros D; Yousef GM; Massobrio M; Fracchioli S; Piccinno R; Gordini G; Diamandis EP
Br J Cancer; 2001 Mar; 84(5):643-50. PubMed ID: 11237385
[TBL] [Abstract][Full Text] [Related]
17. Quantitative assessment and clinical relevance of kallikrein-related peptidase 5 mRNA expression in advanced high-grade serous ovarian cancer.
Gong W; Liu Y; Seidl C; Diamandis EP; Kiechle M; Drecoll E; Kotzsch M; Magdolen V; Dorn J
BMC Cancer; 2019 Jul; 19(1):696. PubMed ID: 31307411
[TBL] [Abstract][Full Text] [Related]
18. The kallikrein gene 5 splice variant 2 is a new biomarker for breast and ovarian cancer.
Yousef GM; White NM; Kurlender L; Michael I; Memari N; Robb JD; Katsaros D; Stephan C; Jung K; Diamandis EP
Tumour Biol; 2004; 25(5-6):221-7. PubMed ID: 15627884
[TBL] [Abstract][Full Text] [Related]
19. Uncovering the clinical impact of kallikrein-related peptidase 5 (KLK5) mRNA expression in the colorectal adenoma-carcinoma sequence.
Papachristopoulou G; Malachias A; Devetzi M; Kamouza E; Scorilas A; Xynopoulos D; Talieri M
Clin Chem Lab Med; 2019 Jul; 57(8):1251-1260. PubMed ID: 30759066
[TBL] [Abstract][Full Text] [Related]
20. Kallikreins 5, 6 and 10 differentially alter pathophysiology and overall survival in an ovarian cancer xenograft model.
Pépin D; Shao ZQ; Huppé G; Wakefield A; Chu CW; Sharif Z; Vanderhyden BC
PLoS One; 2011; 6(11):e26075. PubMed ID: 22102857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
